LA Jolla Pharma (LJPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2007 | 03-2007 | 12-2006 | 09-2006 | 06-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,357 | 3,121 | 3,829 | 7,086 | 3,857 |
| Marketable Securities | 56,822 | 30,086 | 39,080 | 43,070 | 54,037 |
| TOTAL | $61,348 | $33,815 | $43,913 | $51,236 | $59,035 |
| Non-Current Assets | |||||
| PPE Net | 1,623 | 1,965 | 2,333 | 2,794 | 3,258 |
| Intangibles | 3,572 | 3,314 | 3,279 | 3,353 | 3,279 |
| TOTAL | $5,195 | $5,279 | $5,612 | $6,147 | $6,537 |
| Total Assets | $66,543 | $39,094 | $49,525 | $57,383 | $65,572 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,116 | 2,581 | 2,125 | 1,615 | 1,156 |
| Accrued Expenses | 6,306 | 3,627 | 3,932 | 2,835 | 4,045 |
| TOTAL | $7,539 | $6,343 | $6,240 | $4,631 | $5,458 |
| Non-Current Liabilities | |||||
| Long Term Debt | 210 | 175 | 196 | 11 | 43 |
| TOTAL | $210 | $175 | $196 | $11 | $43 |
| Total Liabilities | $7,749 | $6,518 | $6,436 | $4,642 | $5,501 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 39,576 | 39,540 | 32,712 | 32,670 | 32,598 |
| Common Shares | 396 | 329 | 327 | 326 | 326 |
| Retained earnings | -325,144 | -311,627 | -299,757 | -289,063 | -280,525 |
| Other shareholders' equity | -14 | 0 | 0 | 0 | 0 |
| TOTAL | $58,794 | $32,576 | $43,089 | $52,741 | $60,071 |
| Total Liabilities And Equity | $66,543 | $39,094 | $49,525 | $57,383 | $65,572 |